Kimberly McAllister
Psychiatric/Mental Health · Wilmington, NCNPI 1265194682
Payments from drug & device makers
Across 97 payments — averaging $23.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$679
- AbbVie$367
- Teva Pharmaceuticals USA, Inc.$216
- Indivior Inc.$154
- Corium, LLC$152
- Tris Pharma Inc$138
- plus $528 from 12 others
What the payments were for
- Food & beverage$2,16497%
- Education$693%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 21 | $679 |
| AbbVie | 22 | $367 |
| Teva Pharmaceuticals USA, Inc. | 13 | $216 |
| Indivior Inc. | 6 | $154 |
| Corium, LLC | 7 | $152 |
| Tris Pharma Inc | 2 | $138 |
| Alkermes, Inc. | 6 | $120 |
| Johnson & Johnson | 4 | $88 |
| Braeburn Inc. | 3 | $69 |
| Almatica Pharma LLC | 3 | $66 |
| Supernus Pharmaceuticals, Inc. | 2 | $40 |
| Lundbeck LLC | 2 | $38 |
| Avanir Pharmaceuticals, Inc. | 1 | $24 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| Bausch Health US, LLC | 1 | $18 |
| Sunovion Pharmaceuticals Inc. | 1 | $14 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAPLYTA$371
- Dyanavel XR$120
- Quillivant$120
- Quillichew ER$120
How this compares
$2,233 in reported general payments places this provider in the 80th percentile of 947 psychiatric/mental health providers in North Carolina.
See all psychiatric/mental health providers in North Carolina →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ramelteon | 13 | $1,684 |
| Quetiapine Fumarate | 17 | $298 |
| Hydroxyzine Pamoate | 13 | $172 |
| Lamotrigine | 21 | $138 |
| Buspirone Hcl | 13 | $137 |
| Trazodone Hcl | 12 | $122 |
| Fluoxetine Hcl | 11 | $73 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Wilmington
- Kristen MingiaWilmington$8K
- Maryann RichardsonWilmington$6K
- Desiree MatthewsCharlotte$807K
- Benedetto PalomboCharlotte$671K
- Clarence RunnelsCreedmoor$339K
- Lisa SuddrethGastonia$111K
- April NandigamGreensboro$88K
- Hannah NealeyFuquay Varina$75K
- Jessica StoneRocky Mount$63K
- Deborah GranickRaleigh$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.